Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Northwest Biotherapeutics, Inc. (NWBO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.1800-0.0300 (-2.48%)
At close: 3:59PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.77
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 32.5100
52 Week Low 30.9500
50-Day Moving Average 31.2623
200-Day Moving Average 31.3866

Share Statistics

Avg Vol (3 month) 31.3M
Avg Vol (10 day) 31.33M
Shares Outstanding 5851.56M
Implied Shares Outstanding 6N/A
Float 8840.47M
% Held by Insiders 13.69%
% Held by Institutions 10.07%
Shares Short (Nov 29, 2016) 414.14M
Short Ratio (Nov 29, 2016) 413.54
Short % of Float (Nov 29, 2016) 415.09%
Short % of Shares Outstanding (Nov 29, 2016) 411.34%
Shares Short (prior month Oct 30, 2016) 413.83M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:16
Last Split Date 3Sep 25, 2012

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-5,270.23%

Management Effectiveness

Return on Assets (ttm)-207.26%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)1.37M
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)20,700.00%
Gross Profit (ttm)-32.35M
EBITDA -72.2M
Net Income Avi to Common (ttm)-474.11M
Diluted EPS (ttm)-0.6940
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.76M
Total Cash Per Share (mrq)0
Total Debt (mrq)25.8M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.02
Book Value Per Share (mrq)-0.42

Cash Flow Statement

Operating Cash Flow (ttm)-38.27M
Levered Free Cash Flow (ttm)286.08M
Advertisement
Advertisement